Intrinsic Vascular Smooth Muscle Cell Stiffness
Intrinsic Vascular Smooth Muscle Cell Stiffness
批准号:
8586272
负责人:
STEPHEN F VATNER
金额:
$48.74万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-04-01 至 2017-03-31
关键词:
AffectAgeAgingAnimalsAortaAtomic Force MicroscopyBlood VesselsChestCollagenDataElastinEstrogensExtracellular MatrixFemaleGenderGonadal Steroid HormonesGrantHealthHormonesHumanIn VitroLongevityMenopauseMenstruationModelingMonkeysOvariectomyPostmenopausePremenopauseProcessRegulationRodentRodent ModelSex CharacteristicsSmooth Muscle MyocytesTestingThoracic aortaTissue ModelTransforming Growth FactorsWorkabdominal aortaage effectaging populationarterial stiffnesshuman femalein vivomalenonhuman primatenovelolder womenpublic health relevancereconstitutionregional differenceresearch studysenescencespecies difference
中文摘要
描述(申请人提供):众所周知,血管硬度随着年龄的增长而增加,而年龄对动脉硬度的影响在老年女性中相对受到保护。尽管之前大多数关于衰老对血管调节和僵硬的影响的机制工作都是在啮齿动物模型中进行的,但这些数据可以外推到人类身上的程度受到血管僵硬变化发生寿命的显著差异的限制。关于性别差异与年龄的研究更多地局限在啮齿动物身上,因为即使是年龄很大的啮齿动物,雌激素水平也从不会下降,而且它们也不会经历更年期。人们普遍认为,非人灵长类动物是研究性别差异随年龄增长的最佳模型,因为老年雌性猴子的激素和月经变化与老年人类雌性猴子的变化相似。我们以前的研究和对老年猴的初步数据表明,随着年龄的增长,主动脉的硬度增加,这种衰老变化在雄性比雌性更大,腹主动脉(AA)和胸主动脉(TA)的这种变化也更大,这只能部分解释细胞外基质(ECM)的变化。在这里,我们将检验这一新的假设,即血管平滑肌细胞(VSMCs)的内在机制以及VSMC-ECM相互作用的改变也有助于老年男性,特别是AA患者主动脉僵硬的增加,反之,有助于保护绝经前女性的主动脉。初步数据表明,老年男性(OM)培养的VSMC硬度增强,与年轻男性(YM)相比,OM衰老的VSMC数量增加,尤其是在AA中,这一假说得到支持。具体地说,我们将通过两种方法来检验我们的假设。在第一种方法中,我们将使用原子力显微镜(AFM)和人造组织模型来确定年龄和性别对VSMC僵硬和衰老的影响。在第二种方法中,我们将在体内和体外确定这些因素如何解释TA和AA之间主动脉僵硬的区域性差异。
英文摘要
DESCRIPTION (provided by applicant): It is well known that vascular stiffness increases with aging, and that the effects of aging on arterial stiffness are relatively protected in older women. Although most prior mechanistic work on the effects of aging on vascular regulation and stiffness has been conducted in rodent models, the extent to which these data can be extrapolated to humans is limited by the marked differences in lifespan over which changes in vascular stiffness develop. Studies of gender differences with aging are even more limited in rodents, due to the fact that the estrogen levels never decline even in very old rodents, and they do not go through menopause. It is generally agreed that non-humans primates are the best models to study gender differences with aging, since the changes in hormones and menstruation in old female (OF) monkeys parallel those in older human females. Our previous studies and preliminary data in aging monkeys have demonstrated that the stiffness of the aorta increases with aging and this aging alteration is greater in males than females, and also much greater in the abdominal aorta (AA) vs. the thoracic aorta (TA), which is only partially explained by variance in extracellular matrix (ECM). Here, we will test the novel Hypothesis that intrinsic mechanisms in the vascular smooth muscle cells (VSMCs) as well as alterations in VSMC-ECM interaction also contribute to the increased stiffness of the aorta in older males, particularly the AA, and conversely, contribute to the protection in pre-menopausal females. This Hypothesis is supported by Preliminary Data demonstrating enhanced stiffness of VSMC in culture from old male (OM) aortas and showing that the number of senescent VSMC increases in OM compared to young males (YM), particularly in AA. Specifically, we will test our Hypothesis through two approaches. In the first approach, we will determine how VSMC stiffness and senescence are affected by age and gender using atomic force microscopy (AFM) and also an artificial tissue model. In the second approach, we will determine both in vivo and in vitro how these factors may explain the regional differences in aortic stiffness between TA and AA.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Novel Pharmacological Inhibitor of Adenylyl Cyclase Type 5 to Treat Alzheimer's Disease
-
批准号:10608477
-
项目类别:
-
资助金额:$25.21万
-
财政年份:2022
-
负责人:STEPHEN F VATNER
-
依托单位:
Skeletal Muscle and Brown Adipose Mechanisms Mediating Cardiovascular Risk Factor Protection in RGS14 KO
-
批准号:9900047
-
项目类别:
-
资助金额:$53.43万
-
财政年份:2017
-
负责人:STEPHEN F VATNER
-
依托单位:
Angiogenesis Protection Induced by sFRP3 Myocyte/Vascular Cross-Talk
-
批准号:9900045
-
项目类别:
-
资助金额:$56.45万
-
财政年份:2017
-
负责人:STEPHEN F VATNER
-
依托单位:
Vascular Protection in Hibernating Woodchucks
-
批准号:9020511
-
项目类别:
-
资助金额:$45.47万
-
财政年份:2016
-
负责人:STEPHEN F VATNER
-
依托单位:
RGS 14 Disruption, Vascular Effects Leading to Cardioprotection
-
批准号:8888575
-
项目类别:
-
资助金额:$62.94万
-
财政年份:2015
-
负责人:STEPHEN F VATNER
-
依托单位:
RGS 14 Disruption, Vascular Effects Leading to Cardioprotection
-
批准号:9102537
-
项目类别:
-
资助金额:$5.19万
-
财政年份:2015
-
负责人:STEPHEN F VATNER
-
依托单位:
Intrinsic Vascular Smooth Muscle Cell Stiffness
-
批准号:8764029
-
项目类别:
-
资助金额:$7.95万
-
财政年份:2013
-
负责人:STEPHEN F VATNER
-
依托单位:
Longevity and Stress Resistance
-
批准号:8682004
-
项目类别:
-
资助金额:$6.98万
-
财政年份:2013
-
负责人:STEPHEN F VATNER
-
依托单位:
Skeletal Muscle Basis for Improved Exercise Endurance in RGS14 KO
-
批准号:9513046
-
项目类别:
-
资助金额:$50.08万
-
财政年份:2011
-
负责人:STEPHEN F VATNER
-
依托单位:
Skeletal Muscle Basis for Improved Exercise Endurance in AC5 KO
-
批准号:8193326
-
项目类别:
-
资助金额:$46.88万
-
财政年份:2011
-
负责人:STEPHEN F VATNER
-
依托单位:
Skeletal Muscle Basis for Improved Exercise Endurance in AC5 KO
-
批准号:8497469
-
项目类别:
-
资助金额:$43.02万
-
财政年份:2011
-
负责人:STEPHEN F VATNER
-
依托单位:
Skeletal Muscle Basis for Improved Exercise Endurance in RGS14 KO
-
批准号:9113803
-
项目类别:
-
资助金额:$50.08万
-
财政年份:2011
-
负责人:STEPHEN F VATNER
-
依托单位:
Skeletal Muscle Basis for Improved Exercise Endurance in AC5 KO
-
批准号:8323343
-
项目类别:
-
资助金额:$45.33万
-
财政年份:2011
-
负责人:STEPHEN F VATNER
-
依托单位:
Skeletal Muscle Basis for Improved Exercise Endurance in AC5 KO
-
批准号:8725726
-
项目类别:
-
资助金额:$44.88万
-
财政年份:2011
-
负责人:STEPHEN F VATNER
-
依托单位:
Intrinsic Vascular Smooth Muscle Cell Stiffness
-
批准号:7866136
-
项目类别:
-
资助金额:$49.13万
-
财政年份:2010
-
负责人:STEPHEN F VATNER
-
依托单位:
Intrinsic Vascular Smooth Muscle Cell Stiffness
-
批准号:8828759
-
项目类别:
-
资助金额:$48.99万
-
财政年份:2010
-
负责人:STEPHEN F VATNER
-
依托单位:
AC5 Inhibitor Treatment for Heart Failure
-
批准号:8010655
-
项目类别:
-
资助金额:$77.91万
-
财政年份:2010
-
负责人:STEPHEN F VATNER
-
依托单位:
Intrinsic Vascular Smooth Muscle Cell Stiffness
-
批准号:8724853
-
项目类别:
-
资助金额:$44.22万
-
财政年份:2010
-
负责人:STEPHEN F VATNER
-
依托单位:
AC5 Inhibitor Treatment for Heart Failure
-
批准号:7867014
-
项目类别:
-
资助金额:$77.91万
-
财政年份:2010
-
负责人:STEPHEN F VATNER
-
依托单位:
Adenylyl cyclase isoforms in hypertrophy and heart failure
-
批准号:7741542
-
项目类别:
-
资助金额:$46.74万
-
财政年份:2009
-
负责人:STEPHEN F VATNER
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: